Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Efficacy of MMP-inhibiting wound dressings in the treatment of hard-to-heal wounds: a systematic review.

Dissemond J, Augustin M, Dietlein M, Faust U, Keuthage W, Lobmann R, Münter KC, Strohal R, Stücker M, Traber J, Vanscheidt W, Läuchli S.

J Wound Care. 2020 Feb 2;29(2):102-118. doi: 10.12968/jowc.2020.29.2.102.

PMID:
32058850
2.

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.

Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M.

JAMA Dermatol. 2020 Feb 5. doi: 10.1001/jamadermatol.2019.4029. [Epub ahead of print]

PMID:
32022825
3.

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany.

Runge M, Krensel M, Westermann C, Bindl D, Nagels K, Augustin M, Nienhaus A.

Int J Environ Res Public Health. 2020 Jan 9;17(2). pii: E440. doi: 10.3390/ijerph17020440.

4.

Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers.

Lobmann R, Augustin M, Lawall H, Tigges W, Potempa C, Thiem H, Fietz C, Rychlik RP.

J Wound Care. 2019 Dec 2;28(12):808-816. doi: 10.12968/jowc.2019.28.12.808.

PMID:
31825772
5.

Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany.

Topp J, Andrees V, Heesen C, Augustin M, Blome C.

BMJ Open. 2019 Nov 21;9(11):e032859. doi: 10.1136/bmjopen-2019-032859.

6.

Diagnosis and treatment of xerosis cutis - a position paper.

Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P.

J Dtsch Dermatol Ges. 2019 Nov;17 Suppl 7:3-33. doi: 10.1111/ddg.13906.

PMID:
31738016
7.

How should electronic health records be designed? A cross-sectional study in patients with psoriasis.

Klein TM, Augustin M, Otten M.

BMC Med Inform Decis Mak. 2019 Nov 12;19(1):218. doi: 10.1186/s12911-019-0926-5.

8.

Rationale and Design of the Hamburg City Health Study.

Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, Augustin M, der Kellen RB, Beikler T, Behrendt CA, Betz CS, Bokemeyer C, Borof K, Briken P, Busch CJ, Büchel C, Brassen S, Debus ES, Eggers L, Fiehler J, Gallinat J, Gellißen S, Gerloff C, Girdauskas E, Gosau M, Graefen M, Härter M, Harth V, Heidemann C, Heydecke G, Huber TB, Hussein Y, Kampf MO, von dem Knesebeck O, Konnopka A, König HH, Kromer R, Kubisch C, Kühn S, Loges S, Löwe B, Lund G, Meyer C, Nagel L, Nienhaus A, Pantel K, Petersen E, Püschel K, Reichenspurner H, Sauter G, Scherer M, Scherschel K, Schiffner U, Schnabel RB, Schulz H, Smeets R, Sokalskis V, Spitzer MS, Terschüren C, Thederan I, Thoma T, Thomalla G, Waschki B, Wegscheider K, Wenzel JP, Wiese S, Zyriax BC, Zeller T, Blankenberg S.

Eur J Epidemiol. 2019 Nov 8. doi: 10.1007/s10654-019-00577-4. [Epub ahead of print]

PMID:
31705407
9.

[Access to statutory skin cancer screening : Organizational and regional factors in Germany].

Andrees V, Girbig G, Krensel M, Augustin M, Zander N.

Hautarzt. 2020 Jan;71(1):39-45. doi: 10.1007/s00105-019-04494-1. German.

PMID:
31659389
10.

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M.

Qual Life Res. 2020 Feb;29(2):369-380. doi: 10.1007/s11136-019-02296-5. Epub 2019 Oct 26.

PMID:
31655974
11.

[Predictors of Utilization of Cardiovascular and Respiratory Emergency Department Visits - what Impact does the Environment have?]

Krefis AC, Fischereit J, Hoffmann P, Sorbe C, Pinnschmidt H, Augustin M, Augustin J.

Gesundheitswesen. 2019 Oct 15. doi: 10.1055/a-1005-7161. [Epub ahead of print] German.

PMID:
31614385
12.

Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity.

Riepe C, Osada N, Reich A, Augustin M, Zeidler C, Ständer S.

Acta Derm Venereol. 2019 Dec 1;99(13):1288-1290. doi: 10.2340/00015555-3332. No abstract available.

13.

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Sep;17(9):959-974. doi: 10.1111/ddg.13936_g. German.

PMID:
31538739
14.

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Sep;17(9):959-973. doi: 10.1111/ddg.13936.

PMID:
31538732
15.

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):856-870. doi: 10.1111/ddg.13907_g. German.

PMID:
31437372
16.

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schläger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):856-870. doi: 10.1111/ddg.13907.

PMID:
31437363
17.

Education in people with venous leg ulcers based on a brochure about compression therapy: A quasi-randomised controlled trial.

Protz K, Dissemond J, Seifert M, Hintner M, Temme B, Verheyen-Cronau I, Augustin M, Otten M.

Int Wound J. 2019 Dec;16(6):1252-1262. doi: 10.1111/iwj.13172. Epub 2019 Aug 16.

PMID:
31418532
18.

Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris.

Ständer S, Steinke S, Augustin M, Metze D, Loser K, Baeumer D, Sieder C, Luger T.

Acta Derm Venereol. 2019 Nov 1;99(12):1085-1090. doi: 10.2340/00015555-3275.

19.

Towards patients' understanding of health-related quality of life-a mixed-method study in psoriasis and multiple sclerosis.

Andrees V, Westenhöfer J, Blome C, Heesen C, Augustin M, Topp J.

Qual Life Res. 2019 Oct;28(10):2717-2729. doi: 10.1007/s11136-019-02227-4. Epub 2019 Jun 18.

PMID:
31214932
20.

Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional Study.

Anzengruber F, Augustin M, Radtke MA, Thaci D, Yawalkar N, Streit M, Reich K, Drach M, Sorbe C, French LE, Mrowietz U, Maul JT, Itin PH, Navarini AA.

Acta Derm Venereol. 2019 Sep 1;99(10):871-877. doi: 10.2340/00015555-3221.

Supplemental Content

Loading ...
Support Center